- 現金殖利率: 1.65%、總殖利率: 1.65%、5年平均現金配發率: 58.46%
- 要留意資產負債表的未分配盈餘和配息能力, 如果為負值, 可能會無法發放股利
- 股利有2個稅要支出, 分別是綜合所得稅和健保補充保費(單筆股利達2萬元以上, 課2.11%)
| EPS YoY | 現金股利 YoY | 股票股利 YoY | 現金配發率 YoY | 股票配發率 YoY | 全部配發率 YoY | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 (10) | 1.37 | -32.51 | 0.41 | 0.0 | 0.00 | 0 | 29.93 | 48.18 | 0.00 | 0 | 29.93 | 48.18 |
| 2022 (9) | 2.03 | 103.0 | 0.41 | 2.5 | 0.00 | 0 | 20.20 | -49.51 | 0.00 | 0 | 20.20 | -49.51 |
| 2021 (8) | 1.00 | -59.35 | 0.40 | -73.33 | 0.00 | 0 | 40.00 | -34.4 | 0.00 | 0 | 40.00 | -34.4 |
| 2020 (7) | 2.46 | 189.41 | 1.50 | 25.0 | 0.00 | 0 | 60.98 | -56.81 | 0.00 | 0 | 60.98 | -56.81 |
| 2019 (6) | 0.85 | -32.54 | 1.20 | 51.9 | 0.00 | 0 | 141.18 | 125.17 | 0.00 | 0 | 141.18 | 125.17 |
| 2018 (5) | 1.26 | 3.28 | 0.79 | 31.67 | 0.00 | 0 | 62.70 | 27.49 | 0.00 | 0 | 62.70 | 27.49 |
| 2017 (4) | 1.22 | 0 | 0.60 | 0 | 0.00 | 0 | 49.18 | 0 | 0.00 | 0 | 49.18 | 0 |
| 2016 (3) | -2.16 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 |
| EPS QoQ YoY | 本業EPS QoQ YoY | 累計EPS QoQ YoY | |||||||
|---|---|---|---|---|---|---|---|---|---|
| 24Q3 (20) | 0.56 | 3.7 | 12.0 | 0.53 | 51.43 | 211.76 | 1.53 | 57.73 | 47.12 |
| 24Q2 (19) | 0.54 | 25.58 | 58.82 | 0.35 | 34.62 | 12.9 | 0.97 | 125.58 | 79.63 |
| 24Q1 (18) | 0.43 | 22.86 | 115.0 | 0.26 | 23.81 | 18.18 | 0.43 | -69.06 | 115.0 |
| 23Q4 (17) | 0.35 | -30.0 | 75.0 | 0.21 | 23.53 | -52.27 | 1.39 | 33.65 | -32.2 |
| 23Q3 (16) | 0.50 | 47.06 | -46.24 | 0.17 | -45.16 | -76.06 | 1.04 | 92.59 | -43.78 |
| 23Q2 (15) | 0.34 | 70.0 | -41.38 | 0.31 | 40.91 | -27.91 | 0.54 | 170.0 | -41.3 |
| 23Q1 (14) | 0.20 | 0.0 | -41.18 | 0.22 | -50.0 | -26.67 | 0.20 | -90.24 | -41.18 |
| 22Q4 (13) | 0.20 | -78.49 | -60.0 | 0.44 | -38.03 | 15.79 | 2.05 | 10.81 | 105.0 |
| 22Q3 (12) | 0.93 | 60.34 | 220.69 | 0.71 | 65.12 | 57.78 | 1.85 | 101.09 | 270.0 |
| 22Q2 (11) | 0.58 | 70.59 | 314.29 | 0.43 | 43.33 | 126.32 | 0.92 | 170.59 | 338.1 |
| 22Q1 (10) | 0.34 | -32.0 | 466.67 | 0.30 | -21.05 | 400.0 | 0.34 | -66.0 | 466.67 |
| 21Q4 (9) | 0.50 | 72.41 | 247.06 | 0.38 | -15.56 | 246.15 | 1.00 | 100.0 | -59.68 |
| 21Q3 (8) | 0.29 | 107.14 | -19.44 | 0.45 | 136.84 | 50.0 | 0.50 | 138.1 | -82.27 |
| 21Q2 (7) | 0.14 | 133.33 | -94.24 | 0.19 | 216.67 | 139.58 | 0.21 | 250.0 | -91.43 |
| 21Q1 (6) | 0.06 | 117.65 | 50.0 | 0.06 | 123.08 | 700.0 | 0.06 | -97.58 | 50.0 |
| 20Q4 (5) | -0.34 | -194.44 | -230.77 | -0.26 | -186.67 | -174.29 | 2.48 | -12.06 | 185.06 |
| 20Q3 (4) | 0.36 | -85.19 | 0.0 | 0.30 | 162.5 | 0.0 | 2.82 | 15.1 | 0.0 |
| 20Q2 (3) | 2.43 | 5975.0 | 0.0 | -0.48 | -4700.0 | 0.0 | 2.45 | 6025.0 | 0.0 |
| 20Q1 (2) | 0.04 | -84.62 | 0.0 | -0.01 | -102.86 | 0.0 | 0.04 | -95.4 | 0.0 |
| 19Q4 (1) | 0.26 | 0.0 | 0.0 | 0.35 | 0.0 | 0.0 | 0.87 | 0.0 | 0.0 |
| 年/月 | 營收 | 月增率(%) | 去年同期年增率(%) | 累計營收 | 累計營收年增率(%) | 近三月累計營收 | 存貨銷售比 | 自結稅前EPS | 自結稅前累計EPS | 備註(年增率變動50%需說明原因) |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024/11 | 2.36 | -6.5 | 29.06 | 23.51 | 10.05 | 6.99 | N/A | - | ||
| 2024/10 | 2.53 | 20.06 | 32.72 | 21.15 | 8.27 | 6.98 | N/A | - | ||
| 2024/9 | 2.1 | -10.6 | -3.35 | 18.62 | 5.65 | 6.77 | 0.23 | - | ||
| 2024/8 | 2.35 | 1.85 | 18.97 | 16.52 | 6.92 | 6.89 | 0.23 | - | ||
| 2024/7 | 2.31 | 4.01 | 14.28 | 14.17 | 5.15 | 6.74 | 0.23 | - | ||
| 2024/6 | 2.22 | 0.78 | 13.14 | 11.85 | 3.54 | 6.38 | 0.24 | - | ||
| 2024/5 | 2.2 | 12.81 | 10.54 | 9.63 | 1.55 | 6.17 | 0.25 | - | ||
| 2024/4 | 1.95 | -3.07 | 10.68 | 7.43 | -0.83 | 5.42 | 0.28 | - | ||
| 2024/3 | 2.02 | 39.32 | 0.13 | 5.47 | -4.38 | 5.47 | 0.25 | - | ||
| 2024/2 | 1.45 | -28.01 | -26.66 | 3.46 | -6.83 | 5.25 | 0.26 | - | ||
| 2024/1 | 2.01 | 12.15 | 15.68 | 2.01 | 15.68 | 5.63 | 0.25 | - | ||
| 2023/12 | 1.79 | -2.06 | -13.65 | 23.16 | -13.24 | 5.53 | 0.26 | - | ||
| 2023/11 | 1.83 | -3.85 | -27.0 | 21.36 | -13.21 | 5.91 | 0.24 | - | ||
| 2023/10 | 1.9 | -12.57 | -36.34 | 19.53 | -11.65 | 6.06 | 0.24 | - | ||
| 2023/9 | 2.18 | 10.05 | -15.63 | 17.63 | -7.8 | 6.18 | 0.22 | - | ||
| 2023/8 | 1.98 | -2.15 | -22.44 | 15.45 | -6.58 | 5.96 | 0.23 | - | ||
| 2023/7 | 2.02 | 2.96 | -18.52 | 13.47 | -3.69 | 5.98 | 0.23 | - | ||
| 2023/6 | 1.96 | -1.53 | -11.03 | 11.45 | -0.49 | 5.72 | 0.28 | - | ||
| 2023/5 | 1.99 | 12.96 | -2.17 | 9.48 | 2.01 | 5.77 | 0.27 | - | ||
| 2023/4 | 1.77 | -12.31 | -11.96 | 7.49 | 3.18 | 5.75 | 0.27 | - | ||
| 2023/3 | 2.01 | 2.03 | 3.02 | 5.72 | 8.97 | 5.72 | 0.29 | - | ||
| 2023/2 | 1.97 | 13.55 | 34.86 | 3.71 | 12.49 | 5.79 | 0.28 | - | ||
| 2023/1 | 1.74 | -16.28 | -5.34 | 1.74 | -5.34 | 6.32 | 0.26 | - | ||
| 2022/12 | 2.08 | -17.21 | 15.21 | 26.69 | 27.81 | 7.57 | 0.26 | - | ||
| 2022/11 | 2.51 | -16.15 | 23.3 | 24.62 | 29.0 | 8.08 | 0.25 | - | ||
| 2022/10 | 2.99 | 15.87 | 44.15 | 22.11 | 29.68 | 8.12 | 0.24 | - | ||
| 2022/9 | 2.58 | 1.17 | 44.66 | 19.12 | 27.12 | 7.61 | 0.27 | - | ||
| 2022/8 | 2.55 | 2.79 | 31.65 | 16.54 | 24.76 | 7.24 | 0.28 | - | ||
| 2022/7 | 2.48 | 12.42 | 27.69 | 13.99 | 23.58 | 6.73 | 0.3 | - | ||
| 2022/6 | 2.21 | 8.28 | 16.44 | 11.51 | 22.72 | 6.25 | 0.27 | - | ||
| 2022/5 | 2.04 | 1.65 | 10.89 | 9.3 | 24.32 | 6.0 | 0.28 | - | ||
| 2022/4 | 2.01 | 2.61 | 7.22 | 7.26 | 28.69 | 5.42 | 0.31 | - | ||
| 2022/3 | 1.95 | 33.57 | 58.76 | 5.25 | 39.35 | 5.25 | 0.29 | 東南亞疫情較去年穩定，且去年訂單往後遞延，導致越南廠及菲律賓廠營收較去年同期成長58.76%。 | ||
| 2022/2 | 1.46 | -20.3 | 86.76 | 3.3 | 29.93 | 5.1 | 0.3 | 東南亞疫情較去年穩定，且去年訂單往後遞延，導致越南廠及菲律賓廠營收較去年同期成長86.77% | ||
| 2022/1 | 1.84 | 1.89 | 4.58 | 1.84 | 4.58 | 5.67 | 0.27 | - | ||
| 2021/12 | 1.8 | -11.39 | 2.76 | 20.88 | 9.6 | 5.91 | 0.32 | - | ||
| 2021/11 | 2.03 | -1.97 | 13.93 | 19.08 | 10.3 | 5.89 | 0.32 | - | ||
| 2021/10 | 2.07 | 16.28 | 7.13 | 17.05 | 9.88 | 5.8 | 0.32 | - | ||
| 2021/9 | 1.78 | -7.92 | -10.33 | 15.04 | 10.76 | 5.67 | 0.36 | - | ||
| 2021/8 | 1.94 | -0.29 | 17.88 | 13.26 | 14.38 | 5.78 | 0.35 | - | ||
| 2021/7 | 1.94 | 2.51 | 9.28 | 11.32 | 13.8 | 5.68 | 0.36 | - | ||
| 2021/6 | 1.9 | 3.11 | 27.04 | 9.37 | 14.78 | 5.6 | 0.37 | - | ||
| 2021/5 | 1.84 | -1.7 | 73.48 | 7.48 | 12.04 | 4.94 | 0.42 | 因2020年5月菲律賓廠受疫情影響停工，今年營運正常。 | ||
| 2021/4 | 1.87 | 51.93 | 98.58 | 5.64 | 0.45 | 3.88 | 0.53 | 去年同期收入因受新冠肺炎影響 | ||
| 2021/3 | 1.23 | 57.13 | -19.43 | 3.77 | -19.32 | 3.77 | 0.55 | - | ||
| 2021/2 | 0.78 | -55.37 | -48.62 | 2.54 | -19.26 | 4.29 | 0.48 | - | ||
| 2021/1 | 1.76 | 0.11 | 8.36 | 1.76 | 8.36 | 5.29 | 0.39 | - | ||
| 2020/12 | 1.75 | -1.76 | -6.06 | 19.05 | -19.0 | 5.47 | 0.28 | - | ||
| 2020/11 | 1.78 | -7.82 | -14.41 | 17.3 | -20.11 | 5.71 | 0.27 | - | ||
| 2020/10 | 1.94 | -2.68 | -7.78 | 15.51 | -20.72 | 5.57 | 0.28 | - | ||
| 2020/9 | 1.99 | 21.05 | 0.95 | 13.58 | -22.27 | 5.41 | 0.23 | - | ||
| 2020/8 | 1.64 | -7.56 | -18.61 | 11.59 | -25.23 | 4.91 | 0.25 | - | ||
| 2020/7 | 1.78 | 19.17 | -15.82 | 9.94 | -26.22 | 4.33 | 0.29 | - | ||
| 2020/6 | 1.49 | 40.81 | -24.86 | 8.17 | -28.15 | 3.49 | 0.42 | - | ||
| 2020/5 | 1.06 | 12.51 | -45.85 | 6.67 | -28.85 | 3.53 | 0.41 | - | ||
| 2020/4 | 0.94 | -38.36 | -49.88 | 5.61 | -24.37 | 3.99 | 0.37 | - | ||
| 2020/3 | 1.53 | 0.21 | -22.47 | 4.67 | -15.72 | 4.67 | 0.33 | - | ||
| 2020/2 | 1.52 | -5.87 | 11.35 | 3.14 | -12.0 | 5.01 | 0.31 | - | ||
| 2020/1 | 1.62 | -13.21 | -26.5 | 1.62 | -26.5 | 0.0 | N/A | - | ||
| 2019/12 | 1.87 | -10.49 | -10.0 | 23.52 | -15.56 | 0.0 | N/A | - |
